Latest International AIDS Vaccine Initiative Stories
ATLANTA, Aug. 16, 2011 /PRNewswire/ -- GeoVax Labs, Inc.
NEW YORK, July 19, 2011 /PRNewswire/ -- Rabin Martin, a leading global management consultancy working at the crossroads of health, announced today that Dr. Jeffrey L. Sturchio, President & Chief Executive Officer of the Global Health Council, will join the firm in September as Senior Partner.
Flexible, agile and generous funding structures needed to ensure development and delivery of lifesaving new options for HIV prevention ROME, July 19, 2011 /PRNewswire-USNewswire/ -- In the last year, promising trial results and critical scientific breakthroughs have changed the HIV prevention landscape, providing new opportunities for both a broader response to the epidemic with new prevention options and broader clinical and laboratory agendas with new research targets.
ATLANTA, June 23, 2011 /PRNewswire/ -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a third site for testing the therapeutic potential of its HIV/AIDS vaccine.
WASHINGTON, June 8, 2011 /PRNewswire/ -- Fourteen leading scientists and advocacy experts in vaccines and infectious diseases have announced the formation of a new international Foundation to advance and accelerate vaccine research and development against infectious diseases.
An HIV-positive American has become an icon for the potential end of a disease that has claimed the lives of countless millions.
In honor of HIV Vaccine Awareness Day, researchers at Baylor College of Medicine will host a community open house on Wednesday, May 18, at 7 p.m. at the Houston GLBT Community Center, 1900 Kane Street, Houston, TX 77007.
Research conducted at Oregon Health & Science University's Vaccine and Gene Therapy Institute (VGTI) has developed a vaccine candidate in non-human primates that may eventually lead to a vaccine against Human Immunodeficiency Virus (HIV).
ATLANTA, May 4, 2011 /PRNewswire/ -- GeoVax Labs, Inc. (OTCBB: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, today released its 2010 Annual Report and President's Letter to the Company's stockholders.
ATLANTA, April 27, 2011 /PRNewswire/ -- GeoVax Labs, Inc.
- The act of sweetening by admixture of some saccharine substance.